AI Portfolio Summary
In 2025 Q4, REGENERON PHARMACEUTICALS, INC. maintained a portfolio of 4 distinct positions. Conversely, REGENERON PHARMACEUTICALS, INC. completely exited their position in Alnylam Pharmaceutic.
Total Positions
4
Quarter
2025 Q4
Top Holding
NTLA (98.5%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-4 of 4
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NTLA
Intellia Therap...
|
Healthcare | 98.49% | 9.13% |
#1
1
Prev: #2
|
7.0 | no change | no change |
P
S
|
3,702,995 | $33,289,925 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ACET
Adicet Bio, Inc...
|
Healthcare | 1.51% | 0.11% |
#2
2
Prev: #4
|
2.1 | -907,672 | -93.8% |
P
S
|
60,511 | $509,503 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ALNY
Alnylam Pharmac...
|
Healthcare | 0.00% | 90.64% |
Sold All 😨
(Was: #1) |
0.0 | -1,392,303 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ADVM
Adverum Biotech...
|
Healthcare | 0.00% | 0.12% |
Sold All 😨
(Was: #3) |
0.0 | -180,909 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-4 of 4 holdings